The Asia-Pacific (APAC) region has emerged as a leader in the global clinical trial landscape amid a significant increase in clinical trials and growing international recognition. Several key factors have driven this shift, including a diverse and substantial patient population, cost effectiveness in conducting clinical trials, and a favorable regulatory environment.
